Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis

Breast Cancer Research

Volumn 2, Issue 6, 2000, Pages 408-416

  Welch, Danny R ^a   Steeg, Patricia S ^b   Rinker Schaeffer, Carrie W ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

BRMS1; E cadherin; KAI1; KiSS1; Metastasis suppressor genes; MKK4; Nm23

Indexed keywords

CD82 ANTIGEN; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN BRMS 1; PROTEIN KISS 1; PROTEIN NM 23; UNCLASSIFIED DRUG;

ANIMAL CELL; BREAST CANCER; BREAST CARCINOMA; CANCER GENETICS; CARCINOGENESIS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; METASTASIS INHIBITION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHENOTYPE; REVIEW; SUPPRESSOR GENE; TARGET CELL; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; CARCINOMA; CELL ADHESION; DISEASE PROGRESSION; FEMALE; FORECASTING; GENES, TUMOR SUPPRESSOR; HUMANS; KANGAI-1 PROTEIN; MAP KINASE KINASE 4; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034468244     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr87     Document Type: Review

References (93)

1. Cancer statistics 1998
2. Invasion and metastasis
3. The biochemistry of cancer dissemination
4. How cancer spreads
5. Technical considerations for studying cancer metastasis in vivo
6. Angiogenesis and tumor metastasis
7. The metastatic process: Basic research and clinical implications
8. The distribution of secondary growths in cancer of the breast
9. Cancer metastasis: Tumor cell and host organ properties important in metastasis to secondary sites
10. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
11. Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis
12. Cellular basis of site-specific tumor metastasis
13. Modulation of tumor cell gene expression and phenotype by the organ specific metastatic environment
14. The pathologic evaluation of neoplastic diseases
15. What defines a useful marker of metastasis in human cancer?
16. Genetic control of cancer metastasis
17. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate
18. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastasis
19. Genetic and epigenetic regulation of human breast cancer progression and metastasis
20. Differential gene expression in tumor metastasis: Nm23
21. Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances
22. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
23. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display
24. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
25. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein
26. A causal role for E-cadherin in the transition from adenoma to carcinoma
27. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
28. BrMS1: A human breast carcinoma metastasis-suppressor gene
29. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MMK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17
30. Nm23 and tumour metastasis: Basic and translational advances
31. Nm23 expression in breast ductal carcinomas: A ten year follow-up study in a uniform group of node-negative breast cancer patients
32. nm23 - Relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients
33. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity
34. NM23-NDP kinase
35. Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions
36. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential
37. Down-regulation of the Nm23-H1 gene inhibits cell proliferation
38. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro
39. Histidine to aspartate phosphotransferase activity of nm23 proteins: Phosphorylation of aldolase C on Asp-319
40. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis
41. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous cell lung carcinoma are associated with poor differentiation and advanced tumor stages
42. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas; correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression
43. Nm23 expression in endometrial and cervical cancer: Inverse correlation with lymph node involvement and myometrial invasion
44. Reduced nm23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid
45. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1, and nm23-M2, are involved in metastatic suppression of a murine melanoma line
46. Reduced expression of nm23-H1, but not nm23-H2, is concordant with the frequency of lymph node metastasis of human breast cancer
47. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma
48. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity
49. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6
50. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1)
51. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1
52. Down-regulation of 92 kDa type IV collagenase expression by the metastasis suppressor gene KiSS-1
53. Genomic organization of the human KAI1 metastasis-suppressor gene
54. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer
55. Molecular advances in prostate cancer
56. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
57. KaI1, a putative marker for metastatic potential in human breast cancer
58. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene
59. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells
60. E-cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion
61. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells
62. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
63. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model
64. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
65. E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers
66. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
67. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype
68. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11
69. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13
70. TGF-beta signaling, Smads, and tumor suppressors
71. Transforming growth factor-beta signaling in epithelial cells
72. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells
73. An interaction between human colon carcinoma cells and hepatocytes activates transforming growth factor-beta1 in vitro
74. Cloning and characterization of a transforming growth factor beta 1- induced anti-apoptotic adhesion protein TIF2
75. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential
76. Transforming growth factor β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells
77. TGF beta-1 regulation of VEGF production by breast cancer cells
78. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
79. Parathyroid hormone-related protein and bone metastases
80. Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: Facilitated retention in the lung vasculature
81. Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells
82. The integrin α6β1 promotes the survival of metastatic human breast carcinoma cells in mice
83. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin
84. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin
85. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells
86. Role of intermediate filaments in migration, invasion and metastasis
87. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
88. The role of plasminogen activator receptor in cancer invasion and dormancy
89. Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro
90. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor
91. Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes
92. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells
93. Dysregulation of apoptosis in cancer